AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Minglip-P 15 Tablet SR

Prescription Icon
Prescription Required

Marketer

Siskan Pharma

Salt Composition

Glimepiride (2mg) + Metformin (500mg) + Pioglitazone (15mg)

Overview Minglip-P 15 Tablet SR

GlucoReg 15 SR tablets combine medications to manage blood glucose. This formulation, used alongside diet and exercise, improves glycemic control in adult type 2 diabetics. It enhances insulin effectiveness, reducing blood sugar. Always follow your physician's prescribed dosage and duration; take with food to prevent digestive discomfort. If a dose is missed, take it promptly unless nearing the next dose; then, skip and resume your usual schedule. Never double the dose; overdose risks hypoglycemia. Concurrent use with other antidiabetic medications, alcohol, or skipped meals increases hypoglycemia risk; regular blood glucose monitoring is crucial. Common side effects include nausea, diarrhea, abdominal pain, headache, bone fractures, and respiratory infections. Inform your doctor about kidney, liver, or heart conditions before starting. Pregnant or lactating individuals should seek medical advice. Kidney function tests are typically performed before treatment commences. Limit alcohol consumption to mitigate potential side effects.

Uses of Minglip-P 15 Tablet SR

Managing type 2 diabetes

Major Benefits of Minglip-P 15 Tablet SR:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Minglip-P 15 Tablet SR whole; do not crush, chew, or divide it. Administer this medication with food.

Common Side effects of Minglip-P 15 Tablet SR:

  • Hypoglycemia (low blood glucose level)
  • Headache
  • Nausea
  • Diarrhea
  • Dizziness
  • Vomiting
  • Anemia (low number of red blood cells)
  • Weakness
  • Sinus infection

How to use Minglip-P 15 Tablet SR:

Administer this medication precisely as your physician directs, adhering to the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Consume Minglip-P 15 Tablet SR with a meal.

How Minglip-P 15 Tablet SR works:

Minglip-P 15 SR tablets contain a triple-drug formulation: glimepiride, metformin, and pioglitazone. These agents employ distinct actions to enhance glycemic management when monotherapy or dual-drug regimens prove insufficient. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion, thus reducing blood glucose. Metformin, a biguanide, acts by decreasing hepatic glucose production, retarding intestinal glucose absorption, and improving insulin responsiveness. Pioglitazone, a thiazolidinedione, further augments insulin sensitivity.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent alcohol consumption and Minglip-P 15 Tablet SR is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Minglip-P 15 Tablet SR during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to the fetus. A physician will assess the potential benefits against any risks prior to prescribing. Consult your doctor for advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Prolonged-release Minglip-P 15 mg tablets are likely unsuitable for breastfeeding mothers. Available evidence from human studies indicates potential drug transfer to breast milk, posing a risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Exercise caution when administering Minglip-P 15 Tablet SR to individuals with impaired renal function; dosage modification may be necessary. Consult a physician for guidance. Minglip-P 15 Tablet SR is contraindicated in patients exhibiting severe kidney disease. Routine monitoring of kidney function is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Minglip-P 15 SR tablets cautiously, potentially requiring dosage modification under medical supervision. Minglip-P 15 SR tablets are contraindicated in individuals with severe hepatic dysfunction.

What if you forget to take Minglip-P 15 Tablet SR :

Should you forget a dose of Minglip-P 15 Tablet SR, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Minglip-P 15 Tablet SR

LabelValue
Developing Habits No.
Type of Therapy Diabetes Management

FAQs on Minglip-P 15 Tablet SR

Consuming alcohol while taking Minglip-P 15 Tablet SR is unsafe. Alcohol can cause dangerously low blood sugar (hypoglycemia) and raise the risk of lactic acidosis.
Consult your doctor before using Minglip-P 15 Tablet SR if you have congestive heart failure, kidney or liver problems, or eye swelling. Also inform your doctor if you are pregnant, breastfeeding, or premenopausal, and about all medications, vitamins, and herbal supplements you are taking.
Yes, Minglip-P 15 Tablet SR can lead to vitamin B12 deficiency due to its metformin content. Prolonged use inhibits the stomach's absorption of vitamin B12.
Minglip-P 15 Tablet SR can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Therefore, regular blood sugar monitoring is crucial. Always keep a readily available sugar source, such as candy or chocolate, on hand.
Store this medication in its original, tightly closed container, as directed on the label or packaging. Discard any unused medication and keep it out of reach of children, pets, and others.
Minglip-P 15 Tablet SR
94
MRP 115
18% off